Aryn Knight: Clinical Trials

3 trials sponsored by Aryn Knight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn, 1 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Withdrawn 2, Terminated 1

Follow Aryn Knight: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Umbilical Cord Blood in the Treatment of Stroke in Children.
Autologous Human Cord Blood derived Stem Cell injection - Arterial Ischemic Stroke (AIS) in Children
Phase 1WithdrawnAryn Knight2012-09-012024-03-20
Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children
Autologous Human Umbilical Cord Blood - Hearing Loss
Phase 1WithdrawnAryn Knight2011-04-012024-03-20
Autologous Stem Cells for Spinal Cord Injury (SCI) in Children
bone marrow progenitor cells (BMPC) autologous transplantation - Spinal Cord Injury
Phase 1TerminatedAryn Knight102011-04-012024-03-20

Conditions studied

Cerebral Palsy (1)  ·  Hearing Loss (1)  ·  Ischemic Stroke (1)  ·  Spinal Cord Injuries (1)

Interventions

Transplantation, Autologous (1)

Countries

United States (3)

Top investigators

James E. Baumgartner, MD (3)  ·  Linda S. Baumgartner, CCC-SLP, LSLS CERT.AVT (1)  ·  Linda S. Baumgartner, MS, CCC-SLP, LSLS, Cert.AVT (1)  ·  Rex A. Marco, MD (1)  ·  Samir Fakhri, MD (1)  ·  Timothy C. Foster, MD (1)